Inversions are infrequent events in hematological malignancies. We here report the cytogenetic, fluorescence in situ hybridization (FISH), and molecular studies of 2 patients diagnosed with mantle cell lymphoma (MCL) that showed inversions of chromosomes 2 and 6 as part of complex karyotypes. Both patients showed a cytogenetically identical inv(6)(p23q11) detected as a secondary aberration. In addition, both patients had a derivative chromosome 2 which originated by partial deletion of the short arm and a pericentric inversion with different breakpoints on the long arm: der(2)del(2)(p21)inv(2)(p21q11) and der(2)del(2)(p21)inv(2)(p21q13), respectively. The presence of t(11;14)(q13;q32) was confirmed by interphase FISH and by molecular study....
Mantle cell lymphoma (MCL) is a distinct subentity of non-Hodgkin lymphoma, characterized by the chr...
Rearrangements within the chromosome 11q13 region are frequent in hematologic malignancies. 50% of 7...
Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin’s lymphoma with a median patient survival ti...
To better define the incidence and nature of secondary chromosome anomalies in mantle cell lymphoma ...
Mantle cell lymphoma (MCL) is an aggressive, highly proliferative B-cell non-Hodgkin lymphoma, chara...
Mantle cell lymphoma (MCL) is genetically characterized by 11q13 translocations leading to the overe...
Until now, few data on additional chromosomal aberrations in t(11;14)-positive mantle cell lymphomas...
Conventional chromosome analysis (CCA) and interphase fluorescence in situ hybridization (FISH) was ...
We describe a progressive mantle cell lymphoma (MCL) in which multicolor fluorescence in situ hybrid...
Mantle cell lymphoma (MCL), characterised by t(11;14)(q13;q32), has a poor prognosis. Many cases hav...
The translocation t(11;14)(q13;q32) is the genetic hallmark of mantle cell lymphoma (MCL) but is not...
Characterization of chromosome abnormalities in leukemia and lymphoma have contributed to the unders...
We describe two novel chromosomal translocations in two cases of leukemia in which these translocati...
We describe a case of blastoid mantle cell lymphoma with a complex karyotype. The blastoid variant i...
Objectives: Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphomas. ...
Mantle cell lymphoma (MCL) is a distinct subentity of non-Hodgkin lymphoma, characterized by the chr...
Rearrangements within the chromosome 11q13 region are frequent in hematologic malignancies. 50% of 7...
Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin’s lymphoma with a median patient survival ti...
To better define the incidence and nature of secondary chromosome anomalies in mantle cell lymphoma ...
Mantle cell lymphoma (MCL) is an aggressive, highly proliferative B-cell non-Hodgkin lymphoma, chara...
Mantle cell lymphoma (MCL) is genetically characterized by 11q13 translocations leading to the overe...
Until now, few data on additional chromosomal aberrations in t(11;14)-positive mantle cell lymphomas...
Conventional chromosome analysis (CCA) and interphase fluorescence in situ hybridization (FISH) was ...
We describe a progressive mantle cell lymphoma (MCL) in which multicolor fluorescence in situ hybrid...
Mantle cell lymphoma (MCL), characterised by t(11;14)(q13;q32), has a poor prognosis. Many cases hav...
The translocation t(11;14)(q13;q32) is the genetic hallmark of mantle cell lymphoma (MCL) but is not...
Characterization of chromosome abnormalities in leukemia and lymphoma have contributed to the unders...
We describe two novel chromosomal translocations in two cases of leukemia in which these translocati...
We describe a case of blastoid mantle cell lymphoma with a complex karyotype. The blastoid variant i...
Objectives: Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphomas. ...
Mantle cell lymphoma (MCL) is a distinct subentity of non-Hodgkin lymphoma, characterized by the chr...
Rearrangements within the chromosome 11q13 region are frequent in hematologic malignancies. 50% of 7...
Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin’s lymphoma with a median patient survival ti...